Synthon Pharmaceuticals Inc drugs

4 results
Synthon Pharmaceuticals Inc
Usage: Anastrozole Tablets are indicated for the adjuvant treatment of hormone receptor-positive early breast cancer in postmenopausal women, as well as for first-line treatment of locally advanced or metastatic breast cancer (hormone receptor-positive or unknown) and second-line treatment after tamoxifen therapy.
Synthon Pharmaceuticals Inc
Usage: Bicalutamide Tablets, USP 50 mg are indicated for combination therapy with an LHRH analog in the treatment of Stage D2 metastatic carcinoma of the prostate. The 150 mg dosage is not approved for standalone use or with other treatments.
Synthon Pharmaceuticals Inc
Usage: Esterified estrogens and methyltestosterone are indicated for treating moderate to severe vasomotor symptoms associated with menopause in patients not responding to estrogens alone. They are not effective for nervous symptoms or depression without vasomotor symptoms, and their use during pregnancy can harm the fetus.
Synthon Pharmaceuticals Inc
Usage: Levocetirizine dihydrochloride is indicated for relieving symptoms of seasonal and perennial allergic rhinitis and for treating chronic idiopathic urticaria in adults and children aged 6 years and older. Pediatric use is noted for younger patients, subject to marketing exclusivity rights.